Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
Daily summary: Markets Show Slight Optimism Despite the U.S. Shutdown
IBM Shares Rise on Breakthroughs in Quantum Technology
US Open: Wall Street Awaits End of Shutdown
AMD gains 5% in premarket amid positive future AI business forecasts 📈